These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1335397)

  • 1. Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Frederickson's IIB phenotype.
    Crook M; Tutt P
    Clin Sci (Lond); 1992 Nov; 83(5):593-5. PubMed ID: 1335397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sialic acid and acute-phase proteins in hypertriglyceridaemic patients showing the Frederickson's type IIB phenotype.
    Haq S; Tutt P; Haq M; Crook M
    Clin Sci (Lond); 1993 Aug; 85(2):219-22. PubMed ID: 7691460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of serum total sialic acid with serum acute phase proteins and lipoprotein (a) in patients with severe hypertriglyceridaemia.
    Crook M; Haq S; Haq M; Tutt P
    Eur J Clin Invest; 1994 Mar; 24(3):179-81. PubMed ID: 7518393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
    Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
    Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.
    Crook MA; Tutt P; Pickup JC
    Diabetes Care; 1993 Jan; 16(1):57-60. PubMed ID: 8422833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria.
    Crook MA; Earle K; Morocutti A; Yip J; Viberti G; Pickup JC
    Diabetes Care; 1994 Apr; 17(4):305-10. PubMed ID: 8026286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of plasma or serum sialic acid.
    Crook M
    Clin Biochem; 1993 Feb; 26(1):31-8. PubMed ID: 8448836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sialic acid concentration and cardiovascular mortality.
    Lindberg G; Eklund GA; Gullberg B; Råstam L
    BMJ; 1991 Jan; 302(6769):143-6. PubMed ID: 1995133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved procedure for determination of serum lipid-associated sialic acid: application for early diagnosis of colorectal cancer.
    Tautu C; Verazin G; Prorok JJ; Alhadeff JA
    J Natl Cancer Inst; 1988 Oct; 80(16):1333-7. PubMed ID: 3172258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum total sialic acid and lipid-associated sialic acid in normal individuals and patients with myocardial infarction, and their relationship to acute phase proteins.
    Haq M; Haq S; Tutt P; Crook M
    Ann Clin Biochem; 1993 Jul; 30 ( Pt 4)():383-6. PubMed ID: 7691040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum total sialic acid and acute phase proteins in elderly subjects.
    Crook MA; Treloar A; Haq M; Tutt P
    Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):745-7. PubMed ID: 7532440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum sialic acid in pregnancy.
    Crook M; Constable S; Lumb P; Rymer J
    J Clin Pathol; 1997 Jun; 50(6):494-5. PubMed ID: 9378816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between serum total and lipid-bound sialic acid concentration and the severity of coronary atherosclerosis.
    Gokmen SS; Kilicli G; Ozcelik F; Ture M; Gulen S
    J Lab Clin Med; 2002 Aug; 140(2):110-8. PubMed ID: 12228767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of total protein, total and lipid associated serum sialic acid levels in patients with Behçet's disease and control groups.
    Doğan H; Paşaoğlu H; Ekinciler OF; Tatlişen N
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):790-4. PubMed ID: 1488889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum and urine sialic acid levels in renal diseases.
    Ozben T
    Ann Clin Biochem; 1991 Jan; 28 ( Pt 1)():44-8. PubMed ID: 2024933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement.
    Plucinsky MC; Riley WM; Prorok JJ; Alhadeff JA
    Cancer; 1986 Dec; 58(12):2680-5. PubMed ID: 3779617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus.
    Crook MA; Tutt P; Simpson H; Pickup JC
    Clin Chim Acta; 1993 Oct; 219(1-2):131-8. PubMed ID: 7508342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.